GlaxoSmithKline has spent 20 years trying to develop an improved vaccine for tuberculosis, and new data for its lead candidate M72/AS01E suggests it is getting closer to a breakthrough in the disease.

This round brings together mission-aligned leaders across industry, research, and impact investing to advance AI reporting ...

TAIPEI, TAIWAN - Media OutReach Newswire - 27 November 2025 - Responding to the rapidly growing demand for high-density, ...

Chronic respiratory illnesses continue to be a growing health challenge in India. According to recent study, around 55 million people are living with chronic obstructive pulmonary disease ...